Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Usefulness of factor V Leiden mutation testing in clinical practice.

European journal of human genetics : EJHG - 1 Aug 2010

Blinkenberg Ellen Ø, Kristoffersen Ann-Helen, Sandberg Sverre, Steen Vidar M, Houge Gunnar

Abstract excerpt

We have investigated the clinical usefulness of the activated protein C resistance (APCR)/factor V Leiden mutation (FVL) test by sending out questionnaires to all Norwegian physicians who ordered these tests from our publicly funded service laboratory during a 3-month period, and of whom 70% (267...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Activated Protein C Resistance
Share to Factor V
Share to Norway

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Practice Patterns, Physicians'

Share to Surveys and Questionnaires

Share to Thrombophilia

Share to Thrombosis

Share to Venous Thromboembolism

Source

Open in PubMed Open full text

Identifiers

PMID: 20332812
DOI: 10.1038/ejhg.2010.33
PMCID: PMC2987383

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-20332812-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Usefulness of factor V Leiden mutation testing in clinical practice.PMID 20332812Read ↗

Do hospital doctors test for thrombophilia in patients with venous thromboembolism?Semantic proximity Read ↗

Analytic validity of genetic tests to identify factor V Leiden and prothrombin G20210A.Semantic proximity Read ↗

Interpreting results from Factor V Leiden mutation analysis: a cautionary note.Semantic proximity Read ↗

Limitations of a calibrated, quantitative APC-R assay under routine conditions.Semantic proximity Read ↗

The prevalence of activated protein C (APC) resistance and factor V Leiden is significantly higher in patients with retinal vein occlusion without general risk factors. Case-control study and meta-analysis.Semantic proximity Read ↗

Social aspects of genetic testing for factor V Leiden mutation in healthy individuals and their importance for daily practice.Semantic proximity Read ↗

Sensitivity and specificity of the APC resistance assay in detection of individuals with factor V Leiden.Semantic proximity Read ↗

Motivating factors for physician ordering of factor V Leiden genetic tests.Semantic proximity Read ↗

Improved distinction of factor V wild-type and factor V Leiden using a novel prothrombin-based activated protein C resistance assay.Semantic proximity Read ↗

Factor V Leiden: prevalence and thromboembolic complications after total hip replacement in Ireland.Semantic proximity Read ↗

Diagnosis strategies in activated protein C resistance: is genotyping still necessary?Semantic proximity Read ↗

Prevalence of factor V Leiden mutation in young adults with cerebral ischaemia: a case-control study on 225 patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.